PROVIDER PROFILE · NPI 1821048323

Michael RossM.D.

Medical OncologyArlington, TXI

MEDICARE UTILIZATION · PART B · 2024

No data available for this provider in 2024.

PRESCRIBING · PART D · 2024

No data available for this provider in 2024.

QUALITY · MIPS · 2024

Final MIPS score

97.8

Quality

3.5

Cost

61.9

Improvement activities

40.0

Promoting interop.

94.0

Payment adjustment

0.96%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

REFERRAL NETWORK

Where Michael Ross's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 8 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Laboratory Corporation Of America Clinical Laboratory · Dallas, TX	129	717
Laboratory Corporation Of America Clinical Laboratory · Burleson, TX	73	517
TEXAS HEALTH HUGULEY, INC.	66	283
Laboratory Corporation Of America Clinical Laboratory · Fort Worth, TX	34	143
MURNANE, THOMAS	33	88
TEXAS HEALTH HARRIS METHODIST HOSPITAL CLEBURNE	30	87
NPI 1285694364	20	61
Andrew Anyadiegwu Pulmonary Disease · Cleburne, TX	11	32

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history